RT @OncBrothers@twitter.com
Day 3 #GI23 Highlights #CommunityOncology
1. #MOUNTAINEER: Tucat+Trast approved CRC
2. #SUNLIGHT: TAS102+Bev confirmed late option CRC
3. #E2211: Cape+Tem in pNET manuscript
4. #ctDNA kinetics CRC
5. TNT state in RectalCA
@ASCO@twitter.com #OncEd #MedEd @OncoAlert@twitter.com #GISM #MedTwitter
: https://twitter.com/OncBrothers/status/1616940781562134534